InvestorsHub Logo
Followers 4
Posts 549
Boards Moderated 0
Alias Born 04/11/2017

Re: None

Thursday, 12/29/2022 7:32:25 PM

Thursday, December 29, 2022 7:32:25 PM

Post# of 1668
So I had a little free time today and was searching up doctors comparing and explaining different prostate cancer available options, making sure to stay away from the ones speaking specifically in favor of a specific treatment. For instance, I didn't watch any doctors speaking specifically about Tulsa Pro. Based on what I was watching, one doctor spoke favorably about Tulsa but emphasized that there is only 1 documented FDA trial with published results. He said it could be great, but it's too early to tell. Another doctor was high on the procedure, but warned insurance doesn't usually cover much of the procedure. Basically, it's just early at this point based on my very limited research. Once more trials are complete, and reimbursements are finalized, this could really take off if it can find a way to explicitly separate itself from HIFU. It appears significantly better than HIFU, but the tech is similar and HIFU is widely used currently.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PROF News